These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 13827485)
1. [Experimental and clinical results with the cytostatic endoxan in hemoblastoses and carcinomas]. GERHARTZ H Verh Dtsch Ges Inn Med; 1959; 65():218-22. PubMed ID: 13827485 [No Abstract] [Full Text] [Related]
2. [The effect of the cytostatic endoxan and trisethyleniminobenzoquinone on the bone marrow and peripheral blood of the rat]. BIERBRAUER U Folia Haematol (Frankf); 1961 Aug; 5():143-61. PubMed ID: 13869053 [No Abstract] [Full Text] [Related]
3. [Changes in the serum protein picture in metastasizing ovarian carcinoma under the influence of cytostatic therapy (endoxan)]. MURKEN J Z Geburtshilfe Gynakol; 1962 Jul; 159():90-8. PubMed ID: 14477377 [No Abstract] [Full Text] [Related]
4. [Clinical experiences with the cytostatic drug Endoxan]. SCHUELLER H Med Welt; 1962 Feb; 6():307-9. PubMed ID: 13909410 [No Abstract] [Full Text] [Related]
5. [Clinical experiences with the cytostatic drug Endoxan]. KOHOUT J Arzneimittelforschung; 1961 Mar; 11():218-20. PubMed ID: 13757614 [No Abstract] [Full Text] [Related]
6. [Alopecia diffusa in ulcerative colitis and following general cytostatic therapy with Endoxan]. SCHWENZNER G; WALTHER H Z Haut Geschlechtskr; 1961 Oct; 31():221-3. PubMed ID: 13909835 [No Abstract] [Full Text] [Related]
7. [EXPERIENCES WITH TREATMENT OF ADVANCED FEMALE GENITAL CARCINOMA WITH THE CYTOSTATIC ENDOXAN]. DVORAK O Cesk Gynekol; 1965 May; 30():271-5. PubMed ID: 14346478 [No Abstract] [Full Text] [Related]
8. [The diphosphopyridine nucleotide blood level as a criterium for controlled dosage of cytostatics E 39 and endoxan in inoperable tumors]. BOLT W; RITZL F; TOUSSAINT R; ZERLETT G Klin Wochenschr; 1960 Jan; 38():71-4. PubMed ID: 13802378 [No Abstract] [Full Text] [Related]
9. [Experimental data on an antineoplastic preparation Endoxan]. ASTRAKHAN VI Vopr Onkol; 1962; 8(4)():14-22. PubMed ID: 13863010 [No Abstract] [Full Text] [Related]
10. [The treatment of malignant hemoblastoses and neoplasms with Endoxan]. KUEHBOECK J; REIMER EE; STOIBER T Arzneimittelforschung; 1961 Mar; 11():196-9. PubMed ID: 13754857 [No Abstract] [Full Text] [Related]
11. [CONTRIBUTION TO THE MECHANISM OF ACTION OF SOME CYTOSTATICS AND IONIZING RAYS. 1. MORPHOLOGICAL AND FUNCTIONAL STUDIES ON THE BONE MARROW AND SPLEEN OF NORMAL INBRED RATS WITHOUT TRANSPLANTED TUMORS]. SCHNEIDER R Strahlentherapie; 1965 Feb; 126():213-35. PubMed ID: 14271552 [No Abstract] [Full Text] [Related]
12. A SIMPLE QUANTITATIVE METHOD FOR THE INVESTIGATION OF THE INHIBITING ACTION OF CYTOSTATICS ON SUCCINATE DEHYDROGENASE. DOMBRADI GA Enzymologia; 1964 Feb; 26():321-8. PubMed ID: 14117127 [No Abstract] [Full Text] [Related]
13. [Experimental study on newer cytostatic agents]. KENDREY G; BALO J; JUHASZ J; GYENES G; SELLYEI M Orv Hetil; 1962 Feb; 103():257-60. PubMed ID: 14455129 [No Abstract] [Full Text] [Related]
14. [INFLUENCE OF AN ANABOLIC STEROID ON CYTOSTATICALLY INHIBITED ANTIBODY FORMATION IN THE RAT]. DEPPE HD; LUTZMANN L Z Hyg Infektionskr; 1963 Dec; 149():401-6. PubMed ID: 14123272 [No Abstract] [Full Text] [Related]
17. [Effect of some cytostatic preparations on the endocrine system (experimental study)]. MILKU ShM; TSIMEL' G; PETRIA I Vopr Onkol; 1962; 8(3)():86-92. PubMed ID: 14473897 [No Abstract] [Full Text] [Related]